Preimplantation processing of ex vivo-derived vascular biomaterials: Effects on peripheral cell adhesion

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 1, 2013, Pages 123-131

  Uzarski, Joseph S ^a   Van De Walle, Aurore B ^a   McFetridge, Peter S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Allograft; Cell adhesion; Decellularization; Endothelialization; Extracellular matrix

Indexed keywords

ADHESIVE PROPERTIES; ALLOGRAFT; BACTERIAL INFECTIONS; BINDING INTERACTION; BIOLOGICAL SCAFFOLDS; CHEMICAL PROCESSING; CRITICAL EFFECTS; DECELLULARIZATION; DECELLULARIZED; ENDOTHELIALIZATION; EXTRACELLULAR MATRICES; HL-60 CELLS; HOST CELLS; HUMAN UMBILICAL VEINS; IMMUNOGENICITY; IN-VIVO; INNATE RESPONSE; NATIVE STRUCTURES; PERIPHERAL BLOOD; PREFERENTIAL BINDING; PRIMARY CELLS; SODIUM DODECYL SULFATE; SURFACE COVERAGES; TISSUE GRAFTS; TRITON X-100; VASCULAR ENDOTHELIAL CELLS; VASCULAR GRAFTS; VASCULATURE;

BINDING ENERGY; BIOMATERIALS; CELL ADHESION; CHEMICAL INDUSTRY; ENDOTHELIAL CELLS; SCANNING ELECTRON MICROSCOPY; SODIUM; SODIUM CHLORIDE; SODIUM SULFATE; SURFACE CHEMISTRY; TISSUE;

GRAFTS;

ACETONE; ALCOHOL; DODECYL SULFATE SODIUM; SODIUM CHLORIDE; TISSUE SCAFFOLD; TRITON X 100;

ALLOGRAFT; ARTICLE; BLOOD VESSEL GRAFT; CELL ADHESION; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; PROMYELOCYTE; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE; THROMBOCYTE ADHESION; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL SEPARATION; CELL SURVIVAL; HL-60 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; PLATELET ADHESIVENESS; PROSTHESIS IMPLANTATION; SURFACE PROPERTIES; TISSUE SCAFFOLDS;

EID: 84872676354     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34308     Document Type: Article

References (41)

1. Roger LV, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive summary: Heart disease and stroke statistics-2012 Update: A report from the American Heart Association. Circulation 2012;125: 188-197.
2. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T. Technology insight: the evolution of tissue-engineered vascular grafts - From research to clinical practice. Nat Clin Pract Cardiovasc Med 2007;4:389-395.
3. Twine CP, McLain AD. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010: CD001487.
4. Sarkar S, Sales KM, Hamilton G, Seifalian AM. Addressing thrombogenicity in vascular graft construction. J Biomed Mater Res B Appl Biomater 2007;82:100-108.
5. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: A review. J Biomed Mater Res B Appl Biomater 2005;74:570-581.
6. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: A prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-277.
7. Sabik JF, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove DM. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg 2005;79: 544-551; discussion 544-551.
8. Eble JA, Niland S. The extracellular matrix of blood vessels. Curr Pharm Des 2009;15:1385-1400.
9. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009;5:1-13.
10. Randon C, Jacobs B, De Ryck F, Beele H, Vermassen F. Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vasc Surg 2010;51:869-877.
11. Moriyama S, Utoh J, Sun LB, Tagami H, Okamoto K, Kunitomo R, Kitamura N. Antigenicity of cryopreserved arterial allografts: Comparison with fresh and glutaraldehyde treated grafts. ASAIO J 2001;47:202-205.
12. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006;27:3675-3683.
13. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011;32: 3233-3243.
14. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221.
15. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023-2030.
16. Daniel J, Abe K, McFetridge PS. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J 2005;51:252-261.
17. Abousleiman RI, Reyes Y, McFetridge P, Sikavitsas V. The human umbilical vein: A novel scaffold for musculoskeletal soft tissue regeneration. Artif Organs 2008;32:735-742.
18. Chan RW, Rodriguez ML, McFetridge PS. The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration. Tissue Eng Part A 2009;15:3537-3546.
19. Goktas S, Pierre N, Abe K, Dmytryk J, McFetridge PS. Cellular interactions and biomechanical properties of a unique vascularderived scaffold for periodontal tissue regeneration. Tissue Eng Part A 2010;16:769-780.
20. Crouzier T, McClendon T, Tosun Z, McFetridge PS. Inverted human umbilical arteries with tunable wall thicknesses for nerve regeneration. J Biomed Mater Res A 2009;89:818-828.
21. Gui L, Muto A, Chan SA, Breuer CK, Niklason LE. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A 2009;15:2665-2676.
22. Lumpkins SB, Pierre N, McFetridge PS. A mechanical evaluation of three decellularization methods in the design of a xenogeneic scaffold for tissue engineering the temporomandibular joint disc. Acta Biomater 2008;4:808-816.
23. Montoya CV, McFetridge PS. Preparation of ex vivo-based biomaterials using convective flow decellularization. Tissue Eng Part C Methods 2009;15:191-200.
24. Tosun Z, Villegas-Montoya C, McFetridge PS. The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues. J Vasc Surg 2011;54:1451-1460.
25. Issa RI, Engebretson B, Rustom L, McFetridge PS, Sikavitsas VI. The effect of cell seeding density on the cellular and mechanical properties of a mechanostimulated tissue-engineered tendon. Tissue Eng Part A 2011;17(11-12):1479-1487.
26. Afshar-Kharghan V, Thiagarajan P. Leukocyte adhesion and thrombosis. Curr Opin Hematol 2006;13:34-39.
27. McGuigan AP, Sefton MV. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007;28:2547-2571.
28. Daniel J, Abe K, McFetridge PS. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J 2005;51:252-261.
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52: 2745-2756.
30. Vollmar B, Slotta JE, Nickels RM, Wenzel E, Menger MD. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation. Microcirculation 2003;10:143-152.
31. Dardik H, Wengerter K, Qin F, Pangilinan A, Silvestri F, Wolodiger F, Kahn M, Sussman B, Ibrahim IM. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases. J Vasc Surg 2002;35:64-71.
32. Dardik H. A 30-year odyssey with the umbilical vein graft. J Am Coll Surg 2006;203:582-583.
33. Neufang A, Espinola-Klein C, Dorweiler B, Messow CM, Schmiedt W, Vahl CF. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV). J Vasc Surg 2007;46: 280-288.
34. Watson SP. Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des 2009;15:1358-1372.
35. Parang P, Arora R. Coronary vein graft disease: Pathogenesis and prevention. Can J Cardiol 2009;25:e57-e62.
36. Johnson TR, Tomaszewski JE, Carpenter JP. Cellular repopulation of human vein allograft bypass grafts. J Vasc Surg 2000;31: 994-1002.
37. Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs 2003;6:227-235.
38. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 2010;107:4669-4674.
39. Hoh BL, Hosaka K, Downes DP, Nowicki KW, Fernandez CE, Batich CD, Scott EW. Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1a and macrophage inflammatory protein-2-dependent pathway. Circulation 2011;124:2243-2252.
40. Stehbens WE, Wakefield JS, Gilbert-Barness E, Zuccollo JM. Histopathology and ultrastructure of human umbilical blood vessels. Fetal Pediatr Pathol 2005;24:297-315.
41. Gratzer PF, Harrison RD, Woods T. Matrix alteration and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng 2006;12:2975-2983.